Table 1.
Tumor characteristics of 240 invasive breast cancer patients.
| N. (%) | |
|---|---|
| Age (years): median value (range 29–80) | 53 |
| ≤53 | 121 (50) |
| >53 | 119 (50) |
| Histotype | |
| IDC | 205 (86.0) |
| ILC | 17 (7.0) |
| Other | 17 (7.0) |
| unknown | 1 |
| Tumor size (cm) | |
| ≤2.0 | 137 (58) |
| >2.0 | 99 (42) |
| Unknown | 4 |
| Node | |
| Negative | 149 (63) |
| Positive | 86 (37) |
| unknown | 5 |
| Grade | |
| 1 | 18 (8) |
| 2 | 107 (45) |
| 3 | 113 (47) |
| unknown | 2 |
| ER (%) | |
| <1 | 85 (36) |
| ≥1 | 152 (64) |
| unknown | 3 |
| PgR (%) | |
| <1 | 100 (42) |
| ≥1 | 137 (58) |
| unknown | 3 |
| Ki67 (%) | |
| <14 | 83 (35) |
| ≥14 | 154 (65) |
| unknown | 3 |
| HER2 | |
| Negative | 204 (86) |
| Positive | 33 (14) |
| unknown | 3 |
| Molecular Subtype | |
| Luminal A | 75 (32) |
| Luminal B− | 89 (38) |
| Her2+ | 32 (13) |
| TNBC | 41 (17) |
| unknown | 3 |
| NLRP3 | |
| Negative | 112 (50) |
| Positive | 113 (50) |
| unknown | 15 |
| PYCARD | |
| Negative | 154 (69) |
| Positive | 68 (31) |
| unknown | 18 |
| CyclinD1 | |
| Negative | 120 (52) |
| Positive | 109 (48) |
| unknown | 11 |
| MYC | |
| Negative | 158 (68) |
| Positive | 74 (32) |
| unknown | 8 |
| CCND1 | |
| Negative | 106 (70) |
| Positive | 46 (30) |
| unknown | 88 |
| MYC | |
| Negative | 89 (60) |
| Positive | 59 (40) |
| unknown | 92 |
IDC: Invasive ductal carcinoma; ILC: Invasive lobular carcinoma; ER: Estrogen receptor; PgR: Progesterone receptor; HER2: Human epidermal growth factor receptor 2; NLRP3: NOD-like receptor protein 3; PYCARD: Apoptosis-Associated Speck-Like Protein Containing a Pyrin and CARD domain; CCND1: Cyclin D1 gene; MYC protein; MYC gene.